Publications by authors named "G H Sasaki"

Purpose: In the 2016 WHO Classification of Lymphoid Tissue Neoplasms, co-expression of MYC and BCL2 is newly designated as double expressor lymphoma. Patients with primary central nervous system lymphoma with double expressor (DE-PCNSL) have been reported to have a higher risk of recurrence and a worse prognosis than those with PCNSL without double expressor (non-DE-PCNSL). The aim of this study was to determine whether DE-PCNSL has characteristic clinical and MR imaging features compared to non-DE-PCNSL.

View Article and Find Full Text PDF

Purpose: This study aimed to assess the safety and efficacy of endovascular treatment of unruptured pancreatic arcade aneurysms in a single-center series.

Materials And Methods: The electronic medical records of patients who underwent endovascular treatment for unruptured pancreatic arcade aneurysms between 2011 and 2022 at our tertiary center were retrospectively reviewed. The presence of celiac artery stenosis/occlusion; aneurysm number, location, and size; endovascular technique; procedure-related complication incidence; and clinical outcomes were assessed.

View Article and Find Full Text PDF

The induced membrane technique (IMT) is among the most innovative reconstructive methods for clavicle defects after fracture-related infection (FRI). Herein, we report a case in which a clavicle bone defect after FRI was reconstructed with an autogenous cancellous bone graft mixed with β-tricalcium phosphate (β-TCP) in the second stage of the IMT. A 62-year-old male patient with left clavicle fracture underwent open reduction and internal fixation.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates various catheter techniques used to completely occlude different types of renal arteriovenous malformations (rAVMs) in 18 patients over 11 years, analyzing outcomes based on specific classification criteria.
  • Among the patients, 83% achieved complete rAVM occlusion, with some experiencing asymptomatic small renal infarctions, but no major complications were reported.
  • All patients with symptoms saw improvement, and there were no cases of recurrence or growth of the rAVMs during a follow-up period averaging 32 months.
View Article and Find Full Text PDF